Oppenheimer & Co’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-50,000
Closed -$190K 1336
2020
Q1
$190K Hold
50,000
0.01% 1042
2019
Q4
$255K Hold
50,000
0.01% 1082
2019
Q3
$253K Hold
50,000
0.01% 1044
2019
Q2
$309K Buy
+50,000
New +$309K 0.01% 994